Title : Acquired Concurrent EGFR T790M and Driver Gene Resistance From EGFR-TKIs Hampered Osimertinib Efficacy in Advanced Lung Adenocarcinoma: Case Reports.

Pub. Date : 2022

PMID : 35462930






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The other patient acquired EGFR T790M and MET amplification post-dacomitinib and acquired CCDC6-RET fusion after osimertinib treatment. osimertinib ret proto-oncogene Homo sapiens